Green Line Business Group

Texas Congressman Nathaniel Moran (TX-01) recently issued a stark warning in a commentary for The Hill titled "America’s medicine cabinet runs through Beijing," highlighting a dangerous shift in the global pharmaceutical landscape.

Moran argues that the United States has reached a perilous turning point regarding its medical supply chain. Currently, the U.S. is deeply beholden to China for essential drug components, even as Beijing aggressively moves to dominate clinical trials and drug production. According to Moran, this lopsided relationship is more than a trade imbalance; it is a direct threat to national security and the well-being of American patients. Any escalation in geopolitical friction could effectively sever the American public's access to vital medications.

While the U.S. has historically been the pioneer of medical breakthroughs, Moran emphasizes that this leadership is under siege. He calls on Congress to implement long-term reforms that incentivize domestic R&D and manufacturing to counter China’s rapid expansion in the sector.

"Congress must continue to focus on policies that spur pharmaceutical innovation at home beyond the immediate future because China has and will continue to outpace the U.S.," Moran writes. He maintains that the next wave of medical miracles must be "discovered, developed, and produced" on American soil to ensure the safety of the free world.

Read the full piece here: https://thehill.com/opinion/healthcare/5817380-us-china-drug-innovation/

America’s medicine cabinet runs through Beijing The United States is increasingly reliant on China for pharmaceuticals, with the potential for the Chinese Communist Party to gain control of the global supply chain, posing a national security ris…

U.S. Senator Lisa Blunt Rochester, U.S. Senator Chris C***s and Congresswoman Sarah McBride we thank you for your support! Let's pass the now!

Now is the time to pass the Multi-Cancer Early Detection Act, and we are almost there! We are proud to support multi-cancer early detection, and we are getting closer to making early cancer detection a reality!

Great actions happening this week:

Early cancer detection saves lives and it’s time to take action! The 2025 data recently released by the American Cancer Society states that more than 2 million people in America are expected to be diagnosed with cancer, and over 1 million of those cases are expected to be in individuals over the age of 65.

U.S. Senator Lisa Blunt Rochester your support is crucial to Delaware patients. Everyone deserves access to life-saving early detection tests. We are urging Congress to pass the and expand access to critical screenings.

American Cancer Society Cancer Action Network - ACS CAN
https://shorturl.at/NRAyC

American Cancer Society data: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html

Speaker Mike Johnson Rep Hakeem Jeffries Leader John Thune, Senator Chuck Congressman Steve Scalise

Join us for Forever Fighters: A Metastatic Breast Cancer Conversation, a FREE monthly meeting hosted by the Delaware Breast Cancer Coalition! This program invites all stage 4 survivors and thrivers to connect with one another, share experiences, and find support. Let's learn from each other and strengthen our community together! Check out all of our survivor programs at https://debreastcancer.org/programs/survivorprograms/.

Oasis Senior Advisors Delaware Highly recommend!

The Screening Coverage Act was just reintroduced in the U.S. Senate. We urge Senator Tom Carper and U.S. Senator Chris C***s to support the Multi Cancer Early Detection Act to provide seniors access to life-saving early detection technology.

The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act is a game-changer in the fight against cancer. It will expand access to life-saving screenings for Medicare beneficiaries https://bit.ly/40RgNYO. Congresswoman Lisa Blunt Rochester, please support this important legislation.

We couldn’t agree more with the goal of President Biden’s proposed budget to keep solvent. But we need to look at more cost-saving measures than just targeting our medical manufacturers. We need to explore the entire supply chain, including Pharmacy Benefit Managers and other “middle-men” who add to the cost of medication.